KMT2A and precursor B-cell acute lymphoblastic leukemia: Cells from PDX models representing pediatric Ph+, Ph-like, and MLL-rearranged B-ALL patients including patients with TKI-resistant BCR-ABL1(T315I) mutation (Supplementary Table S1) were found in general to be highly sensitive to IODVA1 ex vivo (Supplementary Fig. S3A–C).